Imunon, Inc. is a clinical-stage biotechnology company. Co. is focused on advancing a portfolio of treatments that harness the body's natural mechanisms across an array of human diseases. Co. is developing non-viral Deoxyribonucleic acid (DNA) technology across four modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit a strong immunological response. The third modality, FixPlas, concerns the application of Imunon's DNA technology to produce universal cancer vaccines, also called tumor associated antigen cancer vaccines. We show 4 historical shares outstanding datapoints in our IMNN shares outstanding history coverage, used to compute IMNN market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing IMNN market cap history over the course of time is important for investors
interested in comparing IMNN's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of IMNN versus a peer is one thing; comparing
IMNN market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like IMNN can fluctuate over the course of history.
With this page we aim to empower investors researching IMNN by allowing them to research the IMNN market cap history. |
Free IMNN Email Alerts:
Video: The Importance of Market Cap
